Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jonathan G. Mun, Dan Wang, Denise L. Doerflein Fulk, Mina Fakhary, Scott J. Gualco, Ryan W. Grant & Susan Hazels Mitmesser. (2023) A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults. Journal of Dietary Supplements 0:0, pages 1-13.
Read now
Read now
Paul Pévet. (2016) Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus. Expert Opinion on Therapeutic Targets 20:10, pages 1209-1218.
Read now
Read now
Thomas Roth, Tali Nir & Nava Zisapel. (2015) Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial. Nature and Science of Sleep 7, pages 13-23.
Read now
Read now
Silvia Rivara, Daniele Pala, Annalida Bedini & Gilberto Spadoni. (2015) Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014). Expert Opinion on Therapeutic Patents 25:4, pages 425-441.
Read now
Read now
Nava Zisapel. (2015) Current Phase II investigational therapies for insomnia. Expert Opinion on Investigational Drugs 24:3, pages 401-411.
Read now
Read now
Jacqueline M Walsh, Lynsey A Atkinson, Sarah A Corlett & Gurprit S Lall. (2014) An insight into light as a chronobiological therapy in affective disorders. ChronoPhysiology and Therapy 4, pages 79-85.
Read now
Read now
Alan G Wade, Mildred Farmer, Gil Harari, Naama Fund, Moshe Laudon, Tali Nir, Anat Frydman-Marom & Nava Zisapel. (2014) Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clinical Interventions in Aging 9, pages 947-961.
Read now
Read now
Articles from other publishers (74)
Michele Fornaro, Claudio Caiazza, Giuseppe De Simone, Flavia Rossano & Andrea de Bartolomeis. (2024) Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates. Sleep Medicine 113, pages 198-214.
Crossref
Crossref
Kingston W. C. M. Yeung, Samantha K. M. Lee, Yu Sun Bin & Janet M. Y. Cheung. (2023) Pharmacists’ perspectives and attitudes towards the 2021 down-scheduling of melatonin in Australia using the Theoretical Domains Framework: a mixed-methods study. International Journal of Clinical Pharmacy 45:5, pages 1153-1166.
Crossref
Crossref
Young-Min Park, So-Jin Lee, Jin-Seong Lee, Kyoung-Sae Na, Seung-Gul Kang, Bun-Hee Lee, Ho-Kyoung Yoon & Eui-Joong Kim. (2023) Efficacy and Safety of Prolonged-Release Melatonin for Primary Insomnia in Elderly Patients. Chronobiology in Medicine 5:3, pages 138-143.
Crossref
Crossref
Yushan Duan, Yuan Yang, Weihua Zhu, Linjun Wan, Gang Wang, Jinxi Yue, Qi Bao, Jianlin Shao & Xiaohong Wan. (2023) Melatonin intervention to prevent delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology 14.
Crossref
Crossref
Francy Cruz-Sanabria, Claudia Carmassi, Simone Bruno, Andrea Bazzani, Marco Carli, Marco Scarselli & Ugo Faraguna. (2023) Melatonin as a Chronobiotic with Sleep-promoting Properties. Current Neuropharmacology 21:4, pages 951-987.
Crossref
Crossref
Bradley Wibrow, F. Eduardo Martinez, Erina Myers, Andrew Chapman, Edward Litton, Kwok. M. Ho, Adrian Regli, David Hawkins, Andrew Ford, Frank M. P. van Haren, Simon Wyer, Joe McCaffrey, Alan Rashid, Erin Kelty, Kevin Murray & Matthew Anstey. (2022) Prophylactic melatonin for delirium in intensive care (Pro-MEDIC): a randomized controlled trial. Intensive Care Medicine 48:4, pages 414-425.
Crossref
Crossref
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman, Shantel L. Duffy, Grace Wong, Angela L. D’Rozario, Maria Comas, Isabelle Raisin, Bandana Saini, Christopher J. Gordon, Andrew C. McKinnon, Sharon L. Naismith, Nathaniel S. Marshall, Ronald R. Grunstein & Camilla M. Hoyos. (2021) Safety of higher doses of melatonin in adults: A systematic review and meta‐analysis. Journal of Pineal Research 72:2.
Crossref
Crossref
Hyung Ki Kim & Kwang Ik Yang. (2022) Melatonin and melatonergic drugs in sleep disorders. Translational and Clinical Pharmacology 30:4, pages 163.
Crossref
Crossref
Dewan Md. Sumsuzzman, Jeonghyun Choi, Yunho Jin & Yonggeun Hong. (2021) Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials. Neuroscience & Biobehavioral Reviews 127, pages 459-473.
Crossref
Crossref
Md. Arifur Rahman Chowdhury, Md Mazedul Haq, Narayan Kumar & Chandresh Sharma. (2021) Pathophysiology of Memory Inception and Retrogression and Clock Dependent Divergence in Cognizance. Chronobiology in Medicine 3:2, pages 43-52.
Crossref
Crossref
Allan Giri, Ashokkumar Srinivasan & Isaac Kirubakaran Sundar. (2021) COVID-19: Sleep, Circadian Rhythms and Immunity – Repurposing Drugs and Chronotherapeutics for SARS-CoV-2. Frontiers in Neuroscience 15.
Crossref
Crossref
Irene Moroni, Alfonso Garcia-Bennett, Julia Chapman, Ronald R. Grunstein, Christopher J. Gordon & Maria Comas. (2021) Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: A systematic review. Sleep Medicine Reviews 57, pages 101431.
Crossref
Crossref
Johanna Ell, Fee Benz, Natasza Walter, Lisa Steinmetz, Hanna Brückner, Dirk Lehr, Dieter Riemann & Kai Spiegelhalder. (2021) Chronobiologische Aspekte der InsomnieChronobiological components of insomnia. Somnologie 25:2, pages 110-118.
Crossref
Crossref
Ana M.ª de Andrés Lázaro. (2021) Insomnio en el paciente de edad avanzada: ¿cuándo y cómo tratar?. FMC - Formación Médica Continuada en Atención Primaria 28:5, pages 300-309.
Crossref
Crossref
Jagruti Thoke, Shivangi Patel & Anuradha Majumdar. (2021) Understanding Skin Chronobiology to Unveil and Transform Dermal Chronotherapeutics: Paving the Way for the Future. Chronobiology in Medicine 3:1, pages 8-15.
Crossref
Crossref
Digby J. Quested, Jessica C. Gibson, Ann L. Sharpley, Julia H. Cordey, Alexis Economou, Franco De Crescenzo, Merryn Voysey, Jennifer Lawson, Jennifer M. Rendell, Hasanen Al‐Taiar, Alison Lennox, Farooq Ahmad & John R. Geddes. (2020) Melatonin In Acute Mania Investigation (MIAMI‐UK). A randomized controlled trial of add‐on melatonin in bipolar disorder. Bipolar Disorders 23:2, pages 176-185.
Crossref
Crossref
Robyn Stoianovici, Luigi Brunetti & Christopher D. Adams. (2019) Comparison of Melatonin and Zolpidem for Sleep in an Academic Community Hospital: An Analysis of Patient Perception and Inpatient Outcomes. Journal of Pharmacy Practice 34:1, pages 44-50.
Crossref
Crossref
Atsuro Oishi, Florence Gbahou & Ralf Jockers. 2021. The Human Hypothalamus: Anterior Region. The Human Hypothalamus: Anterior Region
345
356
.
Brahim Selmaoui & Yvan Touitou. (2020) Association Between Mobile Phone Radiation Exposure and the Secretion of Melatonin and Cortisol, Two Markers of the Circadian System: A Review. Bioelectromagnetics 42:1, pages 5-17.
Crossref
Crossref
Nadia Ferlazzo, Giulia Andolina, Attilio Cannata, Maria Giovanna Costanzo, Valentina Rizzo, Monica Currò, Riccardo Ientile & Daniela Caccamo. (2020) Is Melatonin the Cornucopia of the 21st Century?. Antioxidants 9:11, pages 1088.
Crossref
Crossref
Arjuna P De Silva, Madunil A Niriella, Dileepa S Ediriweera, Jerome P De Alwis, Isurujith K Liyanage, Ushanthani Ettickan, Kasun V Liyanapathirana, Chandimani Undugodage, H. Asita Silva & H. Janaka Silva. (2020) Low‐dose melatonin for sleep disturbances in early‐stage cirrhosis: A randomized, placebo‐controlled, cross‐over trial. JGH Open 4:4, pages 749-756.
Crossref
Crossref
Ji Hyun An, Mi Jin Park, Maurizio Fava, David Mischoulon, Hyewon Kim, Jihoon Jang, Jin Pyo Hong, Jun Sang Park & Hong Jin Jeon. (2020) Comparisons Between Successful Versus Unsuccessful Switches From Benzodiazepines or Zolpidem (Z-Drug) to Controlled-Release Melatonin in Patients With Major Depressive Disorder and Insomnia. Frontiers in Psychiatry 11.
Crossref
Crossref
Susannah C. Lumsden, Andrew N. Clarkson & Yusuf Ozgur Cakmak. (2020) Neuromodulation of the Pineal Gland via Electrical Stimulation of Its Sympathetic Innervation Pathway. Frontiers in Neuroscience 14.
Crossref
Crossref
Hossam H. Elsabagh, Eglal Moussa, Sabah A. Mahmoud, Rasha O. Elsaka & Hams Abdelrahman. (2020) Efficacy of Melatonin in prevention of radiation‐induced oral mucositis: A randomized clinical trial. Oral Diseases 26:3, pages 566-572.
Crossref
Crossref
Rosalind Adam, Saravanakumar Kanakarajan, Uzunma Onyeakazi, Malachy Columb & Helen Galley. (2020) Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol. BMJ Open 10:3, pages e034443.
Crossref
Crossref
Hanif Shirinzadeh, Mohammed Ghalia, Alev Tascioglu, Ferial Intissar Adjali, Gulsen Gunesacar, Hande Gurer-Orhan & Sibel Suzen. (2020) Bioisosteric modification on melatonin: synthesis of new naphthalene derivatives, in vitro antioxidant activity and cytotoxicity studies. Brazilian Journal of Pharmaceutical Sciences 56.
Crossref
Crossref
M. L. Churkova. (2020) Reactive Changes of Endocrine Cells of Intestinal Mucosal Epithelium with Administration of Melatonin or Doxylamine Succinate (Electron Microscopic Study). Cell and Tissue Biology 14:1, pages 57-64.
Crossref
Crossref
Jan Frölich, Alfred Wiater & Gerd Lehmkuhl. (2019) Melatonin in der Behandlung von Insomnien und Schlaf-Wach-Rhythmusstörungen im Kindes- und JugendalterMelatonin in the treatment of insomnia and sleep-wake rhythm disorders in children and adolescents. Somnologie 23:4, pages 261-270.
Crossref
Crossref
Stefano Comai, Martha Lopez-Canul, Danilo De Gregorio, Ada Posner, Mohamed Ettaoussi, Fabrizia Claudia Guarnieri & Gabriella Gobbi. (2019) Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives. Pharmacological Research 144, pages 343-356.
Crossref
Crossref
Adam Wichniak, Aleksandra Wierzbicka, Katarzyna Gustavsson, Joanna Szmyd & Wojciech Jernajczyk. (2019) Melatonin in the treatment of Circadian Rhythm Sleep-Wake Disorders – the principles of choosing the right time and dose of administration. Pharmacotherapy in Psychiatry and Neurology 34:4, pages 263-283.
Crossref
Crossref
Jinju LeeYoungsin HanHyun Hee ChoMee-Ran Kim. (2019) Sleep Disorders and Menopause. Journal of Menopausal Medicine 25:2, pages 83.
Crossref
Crossref
A. Yu. Melnikov. (2019) Acute insomnia: natural course and correction modalities. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:4, pages 28.
Crossref
Crossref
Rujin Long, Yousheng Zhu & Shusheng Zhou. (2019) Therapeutic role of melatonin in migraine prophylaxis. Medicine 98:3, pages e14099.
Crossref
Crossref
David N. Neubauer. 2019. Handbook of Sleep Research. Handbook of Sleep Research
639
648
.
Derk-Jan Dijk & Hans-Peter Landolt. 2019. Sleep-Wake Neurobiology and Pharmacology. Sleep-Wake Neurobiology and Pharmacology
441
481
.
Pawel P. Posadzki, Ram Bajpai, Bhone Myint Kyaw, Nicola J. Roberts, Amnon Brzezinski, George I. Christopoulos, Ushashree Divakar, Shweta Bajpai, Michael Soljak, Gerard Dunleavy, Krister Jarbrink, Ei Ei Khaing Nang, Chee Kiong Soh & Josip Car. (2018) Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action. BMC Medicine 16:1.
Crossref
Crossref
B. RÁCZ, M. DUŠKOVÁ, L. STÁRKA, V. HAINER & M. KUNEŠOVÁ. (2018) Links Between the Circadian Rhythm, Obesity and the Microbiome. Physiological Research, pages S409-S420.
Crossref
Crossref
Roseanne Luther & Anne McLeod. (2018) The effect of chronotherapy on delirium in critical care - a systematic review. Nursing in Critical Care 23:6, pages 283-290.
Crossref
Crossref
Emil Kostovski, Elena Frigato, Mladen Savikj, Anders Dahm, Per Morten Sandset, Marie-Christine Mowinckel, Grethe Skretting, Bjarne Østerud, Cristiano Bertolucci & Per Ole Iversen. (2018) Normalization of disrupted clock gene expression in males with tetraplegia: a crossover randomized placebo-controlled trial of melatonin supplementation. Spinal Cord 56:11, pages 1076-1083.
Crossref
Crossref
Nava Zisapel. (2018) New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology 175:16, pages 3190-3199.
Crossref
Crossref
Tobias Atkin, Stefano Comai & Gabriella Gobbi. (2018) Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews 70:2, pages 197-245.
Crossref
Crossref
F. Eduardo Martinez, Matthew Anstey, Andrew Ford, Brigit Roberts, Miranda Hardie, Robert Palmer, Lynn Choo, David Hillman, Michael Hensley, Erin Kelty, Kevin Murray, Bhajan Singh & Bradley Wibrow. (2017) Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial. Trials 18:1.
Crossref
Crossref
Romain Duroux, Marouan Rami, Elodie Landagaray, Mohamed Ettaoussi, Daniel-Henri Caignard, Philippe Delagrange, Patricia Melnyk & Saïd Yous. (2017) Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT 1 /MT 2 ) and serotoninergic (5-HT 2C ) dual ligands. European Journal of Medicinal Chemistry 141, pages 552-566.
Crossref
Crossref
Jean Boutin, Anne Bonnaud, Chantal Brasseur, Olivier Bruno, Nolwenn Lepretre, Peter Oosting, Sophie Coumailleau, Philippe Delagrange, Olivier Nosjean & Céline Legros. (2017) New MT2 Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists. International Journal of Molecular Sciences 18:7, pages 1347.
Crossref
Crossref
Xiao Meng, Ya Li, Sha Li, Yue Zhou, Ren-You Gan, Dong-Ping Xu & Hua-Bin Li. (2017) Dietary Sources and Bioactivities of Melatonin. Nutrients 9:4, pages 367.
Crossref
Crossref
Annabelle Ballesta, Pasquale F. Innominato, Robert Dallmann, David A. Rand & Francis A. Lévi. (2017) Systems Chronotherapeutics. Pharmacological Reviews 69:2, pages 161-199.
Crossref
Crossref
Shazia Jehan, Giardin Jean-Louis, Ferdinand Zizi, Evan Auguste, Seitikurippu R. Pandi-Perumal, Ravi Gupta, Hrayr Attarian, Samy I. McFarlane, Rüdiger Hardeland & Amnon Brzezinski. (2017) Sleep, melatonin, and the menopausal transition: What are the links?. Sleep Science.
Crossref
Crossref
Andrew H. Ford, Leon Flicker, Jurgen Passage, Bradley Wibrow, Matthew Anstey, Mark Edwards & Osvaldo P. Almeida. (2016) The Healthy Heart-Mind trial: melatonin for prevention of delirium following cardiac surgery: study protocol for a randomized controlled trial. Trials 17:1.
Crossref
Crossref
Annette van Maanen, Anne Marie Meijer, Kristiaan B. van der Heijden & Frans J. Oort. (2016) The effects of light therapy on sleep problems: A systematic review and meta-analysis. Sleep Medicine Reviews 29, pages 52-62.
Crossref
Crossref
Soafara Andrianome, Laurent Hugueville, René de Seze, Maïté Hanot-Roy, Kelly Blazy, Christelle Gamez & Brahim Selmaoui. (2016) Disturbed sleep in individuals with idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF): Melatonin assessment as a biological marker. Bioelectromagnetics 37:3, pages 175-182.
Crossref
Crossref
J. Laermans & I. Depoortere. (2016) Chronobesity: role of the circadian system in the obesity epidemic. Obesity Reviews 17:2, pages 108-125.
Crossref
Crossref
Elodie Landagaray, Mohamed Ettaoussi, Romain Duroux, Jean A. Boutin, Daniel-Henri Caignard, Philippe Delagrange, Patricia Melnyk, Pascal Berthelot & Saïd Yous. (2016) Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives. European Journal of Medicinal Chemistry 109, pages 360-370.
Crossref
Crossref
Chih-Wei Sung, Kai-Yun Chen, Yung-Hsiao Chiang, Wen-Ta Chiu, Ju-Chi Ou, Hsin-Chien Lee, Shin-Han Tsai, Jia-Wei Lin, Che-Ming Yang, Yan-Rou Tsai, Kuo-Hsing Liao, Gunng-Shinng Chen, Wei-Jiun Li & Jia-Yi Wang. (2016) Heart rate variability and serum level of insulin-like growth factor-1 are correlated with symptoms of emotional disorders in patients suffering a mild traumatic brain injury. Clinical Neurophysiology 127:2, pages 1629-1638.
Crossref
Crossref
Sebastian C. HolstAmandine ValomonHans-Peter Landolt. (2016) Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy. Annual Review of Pharmacology and Toxicology 56:1, pages 577-603.
Crossref
Crossref
David C. Klein. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
312
322.e5
.
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
65
76
.
Pilar García-García, Francisco López-Muñoz & Cecilio Álamo. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
193
202
.
Hua-Wei Huang, Bo-Lu Zheng, Li Jiang, Zong-Tong Lin, Guo-Bin Zhang, Ling Shen & Xiu-Ming Xi. (2015) Effect of oral melatonin and wearing earplugs and eye masks on nocturnal sleep in healthy subjects in a simulated intensive care unit environment: which might be a more promising strategy for ICU sleep deprivation?. Critical Care 19:1.
Crossref
Crossref
Klaus Wahle. (2015) Retardiertes Melatonin in der Behandlung der primären InsomnieProlonged-release melatonin for the treatment of primary insomnia. Review. MMW - Fortschritte der Medizin 157:S7, pages 14-18.
Crossref
Crossref
Gilberto Spadoni, Annalida Bedini, Simone Lucarini, Michele Mari, Daniel-Henri Caignard, Jean A. Boutin, Philippe Delagrange, Valeria Lucini, Francesco Scaglione, Alessio Lodola, Franca Zanardi, Daniele Pala, Marco Mor & Silvia Rivara. (2015)
Highly Potent and Selective MT
2
Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines
. Journal of Medicinal Chemistry 58:18, pages 7512-7525.
Crossref
Crossref
Carol Enderlin, Janet Rooker, Susan Ball, Dawn Hippensteel, Joanne Alderman, Sarah Jean Fisher, Nanci McLeskey & Kerry Jordan. (2015) Summary of factors contributing to falls in older adults and nursing implications. Geriatric Nursing 36:5, pages 397-406.
Crossref
Crossref
Nava Zisapel. (2015) Safety of melatonin. Journal of Paediatrics and Child Health 51:8, pages 840-841.
Crossref
Crossref
Emma L Arbon, Malgorzata Knurowska & Derk-Jan Dijk. (2015) Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people. Journal of Psychopharmacology 29:7, pages 764-776.
Crossref
Crossref
Yan Ma, Ming Dong, Carol Mita, Shuchen Sun, Chung-Kang Peng & Albert C. Yang. (2015) Publication analysis on insomnia: how much has been done in the past two decades?. Sleep Medicine 16:7, pages 820-826.
Crossref
Crossref
Kenneth D. Phillips & Mary E. Gunther. 2015. Sleep Medicine. Sleep Medicine
167
179
.
Huawei Huang, Li Jiang, Ling Shen, Guobin Zhang, Bo Zhu, Jiajia Cheng & Xiuming Xi. (2014) Impact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial. Trials 15:1.
Crossref
Crossref
David Hevia, Juan C. Mayo, Dun-Xian Tan, Aida Rodriguez-Garcia & Rosa M. Sainz. (2014) Melatonin Enhances Photo-Oxidation of 2′,7′-Dichlorodihydrofluorescein by an Antioxidant Reaction That Renders N1-Acetyl-N2-Formyl-5-Methoxykynuramine (AFMK). PLoS ONE 9:10, pages e109257.
Crossref
Crossref
Moshe Laudon & Anat Frydman-Marom. (2014) Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders. International Journal of Molecular Sciences 15:9, pages 15924-15950.
Crossref
Crossref
Ritva Lähteenmäki, Juha Puustinen, Tero Vahlberg, Alan Lyles, Pertti J. Neuvonen, Markku Partinen, Ismo Räihä & Sirkka-Liisa Kivelä. (2014) Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial. British Journal of Clinical Pharmacology 77:6, pages 975-985.
Crossref
Crossref
Amnon Brzezinski. (2014) Possible Role of Exogenous Melatonin and Melatonin-Receptor-Agonists in the Treatment of Menopause―Associated Sleep Disturbances. Open Journal of Obstetrics and Gynecology 04:06, pages 309-320.
Crossref
Crossref
Henry T. Peng, Fethi Bouak, Oshin Vartanian & Bob Cheung. (2013) A physiologically based pharmacokinetics model for melatonin—Effects of light and routes of administration. International Journal of Pharmaceutics 458:1, pages 156-168.
Crossref
Crossref
Analyne M. Schroeder & Christopher S. Colwell. (2013) How to fix a broken clock. Trends in Pharmacological Sciences 34:11, pages 605-619.
Crossref
Crossref
Cigdem Karaaslan, Hachemi Kadri, Tulay Coban, Sibel Suzen & Andrew D. Westwell. (2013) Synthesis and antioxidant properties of substituted 2-phenyl-1H-indoles. Bioorganic & Medicinal Chemistry Letters 23:9, pages 2671-2674.
Crossref
Crossref
Aida Rodriguez‐Garcia, Juan C. Mayo, David Hevia, Isabel Quiros‐Gonzalez, Maria Navarro & Rosa M. Sainz. (2012) Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine‐induced apoptosis. Journal of Pineal Research 54:1, pages 33-45.
Crossref
Crossref